Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

PET/Computed Tomography in Multiple Myeloma and Marrow Disease: A Fluorodeoxyglucose-Centered Clinical Approach in the Era of Emerging Tracers.

Created on 17 Nov 2026

Authors

Gürsan Kaya, Murat Fani Bozkurt

Published in

Magnetic resonance imaging clinics of North America. Volume 35. Issue 1. Pages 119-134. Epub Oct 23, 2026.

Abstract

This review presents a clinically oriented framework for PET/computed tomography (CT) in multiple myeloma and marrow disease, centered on the current routine role of FDG PET/CT. The discussion focuses on practical indications, imaging patterns, interpretation pitfalls, treatment response assessment, and structured reporting. The review also addresses the complementary role of whole-body MR imaging and the selective but growing relevance of alternative tracers such as fluorocholine, methionine, and CXCR4-targeted agents. The aim is to provide a pragmatic and clinically grounded roadmap that reflects current practice while identifying the biologic situations in which FDG alone may be insufficient.

PMID:
43039494
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement